Landscapes / Targets
NY-ESO-1
4 drugs act on NY-ESO-1, in 4 active trials · Any stage · updated 18 Nov 2026
FollowEvery change as it happens, and a Monday email
Drugs4
| Drug | How it works | Company | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 3 | Mar 2032Phase 3 trial completes | |||
| Next date | Mar 2032 · Phase 3 trial completes | ||||
| Also tested for | Synovial Sarcomas | ||||
| Open drug page | |||||
Gene therapy substances |
USWM CT +1 |
Phase 2 | — | ||
| How it works | A gene therapy | ||||
| Also tested for | Neoplasms | ||||
| Open drug page | |||||
— |
Phase 1 | 25 Apr 2027Phase 1 trial completes | |||
| Next date | 25 Apr 2027 · Phase 1 trial completes | ||||
| Also tested for | Sarcoma, Lung Cancers and 1 more | ||||
| Open drug page | |||||
— |
Phase 1 | 10 Nov 2027Phase 1 trial completes | |||
| Next date | 10 Nov 2027 · Phase 1 trial completes | ||||
| Also tested for | Advanced Solid Tumors | ||||
| Open drug page | |||||
No drugs match “”.
About this list
- Checked
- 4 of 4 drugs. How we check
- Matches
- The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026